GSE179235 MEK NRAS inhibition 5 v 6 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE179235_MEK_NRAS inhibition_5_v_6_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE179235_MEK_NRAS inhibition_5_v_6_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE179235_MEK_NRAS inhibition_5_v_6_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE179235_MEK_NRAS inhibition_5_v_6_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

WD repeat domain 46

Gene

PAX8 antisense RNA 1

Gene

taxilin gamma Y-linked (pseudogene)

Gene

small nucleolar RNA host gene 8

Gene

glucosylceramidase beta 1 like, pseudogene

Gene

family with sequence similarity 27 member C

Gene

MIR4458 host gene

Gene

MT-ND4 pseudogene 12

Gene

UBA6 divergent transcript

Gene

family with sequence similarity 86, member C

  • Gene

    WD repeat domain 46


  • Gene

    PAX8 antisense RNA 1


  • Gene

    taxilin gamma Y-linked (pseudogene)


  • Gene

    small nucleolar RNA host gene 8


  • Gene

    glucosylceramidase beta 1 like, pseudogene


  • Gene

    family with sequence similarity 27 member C



  • Gene

    MT-ND4 pseudogene 12


  • Gene

    UBA6 divergent transcript


  • Gene

    family with sequence similarity 86, member C

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.